EU Decision Time On Expanded Use Of BMS/Ipsen Pharma Cancer Drug Combo
The European Medicines Agency may decide this week on a dozen requests by companies seeking new uses of their approved drugs.
The European Medicines Agency may decide this week on a dozen requests by companies seeking new uses of their approved drugs.